| RS2533419466 |
LAMA2
|
Health Risk |
Likely pathogenic |
Merosin deficient congenital muscular dystrophy, Muscular dystrophy |
| RS2533419663 |
DMD
|
Health Risk |
Likely pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2533421655 |
APC
|
Health Risk |
Pathogenic |
Familial adenomatous polyposis 1, Familial adenomatous polyposis 1 |
| RS2533421902 |
APC
|
Health Risk |
Pathogenic |
Familial adenomatous polyposis 1, Familial adenomatous polyposis 1 |
| RS2533422611 |
APC
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 1 |
| RS2533422981 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS2533424724 |
LAMA2
|
Health Risk |
Likely pathogenic |
— |
| RS2533424772 |
LAMA2
|
Health Risk |
Pathogenic |
LAMA2-related muscular dystrophy, LAMA2-related muscular dystrophy |
| RS2533424883 |
LAMA2
|
Health Risk |
Pathogenic |
LAMA2-related muscular dystrophy, LAMA2-related muscular dystrophy |
| RS2533424901 |
APC
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2533425213 |
APC
|
Health Risk |
Pathogenic |
Familial adenomatous polyposis 1, Familial adenomatous polyposis 1 |
| RS2533425839 |
APC
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 1 |
| RS2533425949 |
APC
|
Health Risk |
Pathogenic |
Familial adenomatous polyposis 1, Familial adenomatous polyposis 1 |
| RS2533426606 |
APC
|
Health Risk |
Pathogenic |
Familial adenomatous polyposis 1, Familial adenomatous polyposis 1 |
| RS2533427178 |
APC
|
Health Risk |
Pathogenic |
Familial adenomatous polyposis 1, Familial adenomatous polyposis 1 |
| RS2533427808 |
APC
|
Health Risk |
Pathogenic |
Familial adenomatous polyposis 1, Familial adenomatous polyposis 1 |
| RS2533427923 |
APC
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2533428670 |
APC
|
Health Risk |
Pathogenic/Likely pathogenic |
Familial adenomatous polyposis 1, Hereditary cancer-predisposing syndrome |
| RS2533429191 |
SLC17A5
|
Health Risk |
Likely pathogenic |
Salla disease, Sialic acid storage disease |
| RS2533429249 |
SLC17A5
|
Health Risk |
Pathogenic |
Salla disease, Salla disease |
| RS2533429370 |
SLC17A5
|
Health Risk |
Likely pathogenic |
Salla disease, Sialic acid storage disease |
| RS2533429379 |
APC
|
Health Risk |
Pathogenic |
Familial adenomatous polyposis 1, Familial adenomatous polyposis 1 |
| RS2533429418 |
SLC17A5
|
Health Risk |
Pathogenic |
Salla disease, Salla disease |
| RS2533429445 |
SLC17A5
|
Health Risk |
Likely pathogenic |
Salla disease, Sialic acid storage disease |
| RS2533429504 |
APC
|
Health Risk |
Pathogenic |
Familial adenomatous polyposis 1, Familial adenomatous polyposis 1 |
| RS2533429537 |
SLC17A5
|
Health Risk |
Pathogenic |
Salla disease, Salla disease |
| RS2533429681 |
SLC17A5
|
Health Risk |
Likely pathogenic |
Salla disease, Sialic acid storage disease |
| RS2533429691 |
SLC17A5
|
Health Risk |
Pathogenic |
Salla disease, Salla disease |
| RS2533429751 |
SLC17A5
|
Health Risk |
Pathogenic/Likely pathogenic |
Salla disease, Sialic acid storage disease |
| RS2533430086 |
APC
|
Health Risk |
Pathogenic |
Familial adenomatous polyposis 1, Familial adenomatous polyposis 1 |
| RS2533430713 |
APC
|
Health Risk |
Pathogenic |
Familial adenomatous polyposis 1, Familial adenomatous polyposis 1 |
| RS2533430795 |
APC
|
Health Risk |
Pathogenic |
Familial adenomatous polyposis 1, Familial adenomatous polyposis 1 |
| RS2533430847 |
PKHD1
|
Health Risk |
Likely pathogenic |
Polycystic kidney disease 4, Polycystic kidney disease 4 |
| RS2533431242 |
APC
|
Health Risk |
Pathogenic |
Familial adenomatous polyposis 1, Classic or attenuated familial adenomatous polyposis |
| RS2533431703 |
PKHD1
|
Health Risk |
Pathogenic |
Autosomal recessive polycystic kidney disease, Autosomal recessive polycystic kidney disease |
| RS2533431743 |
PKHD1
|
Health Risk |
Likely pathogenic |
Polycystic kidney disease 4, Polycystic kidney disease 4 |
| RS2533433163 |
LAMA2
|
Health Risk |
Pathogenic |
LAMA2-related muscular dystrophy, LAMA2-related muscular dystrophy |
| RS2533433193 |
APC
|
Health Risk |
Pathogenic |
Familial adenomatous polyposis 1, Familial adenomatous polyposis 1 |
| RS2533434126 |
PKHD1
|
Health Risk |
Likely pathogenic |
Polycystic kidney disease 4, Polycystic kidney disease 4 |
| RS2533434563 |
APC
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 1 |
| RS2533435197 |
APC
|
Health Risk |
Pathogenic |
Familial adenomatous polyposis 1, Familial adenomatous polyposis 1 |
| RS2533435581 |
PKHD1
|
Health Risk |
Likely pathogenic |
Polycystic kidney disease 4, Polycystic kidney disease 4 |
| RS2533435674 |
PKHD1
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive polycystic kidney disease, Polycystic kidney disease 4 |
| RS2533436382 |
APC
|
Health Risk |
Likely pathogenic |
Familial adenomatous polyposis 1, Familial adenomatous polyposis 1 |
| RS2533436971 |
APC
|
Health Risk |
Pathogenic/Likely pathogenic |
Familial adenomatous polyposis 1, Hereditary cancer-predisposing syndrome |
| RS2533437015 |
PKHD1
|
Health Risk |
Pathogenic |
Autosomal recessive polycystic kidney disease, Autosomal recessive polycystic kidney disease |
| RS2533437734 |
APC
|
Health Risk |
Pathogenic |
Familial adenomatous polyposis 1, Familial adenomatous polyposis 1 |
| RS2533437974 |
PKHD1
|
Health Risk |
Pathogenic |
Autosomal recessive polycystic kidney disease, Autosomal recessive polycystic kidney disease |
| RS2533438023 |
LCA5
|
Health Risk |
Likely pathogenic |
— |
| RS2533438140 |
LCA5
|
Health Risk |
Likely pathogenic |
Leber congenital amaurosis 5, Leber congenital amaurosis 5 |
| RS2533438238 |
LCA5
|
Health Risk |
Pathogenic |
— |
| RS2533438306 |
PKHD1
|
Health Risk |
Pathogenic |
Polycystic kidney disease 4, Polycystic kidney disease 4 |
| RS2533438349 |
LCA5
|
Health Risk |
Pathogenic |
— |
| RS2533438454 |
LCA5
|
Health Risk |
Pathogenic |
— |
| RS2533438513 |
PKHD1
|
Health Risk |
Likely pathogenic |
Polycystic kidney disease 4, Polycystic kidney disease 4 |
| RS2533438579 |
LCA5
|
Health Risk |
Pathogenic/Likely pathogenic |
Leber congenital amaurosis 5, Leber congenital amaurosis 5 |
| RS2533438607 |
LCA5
|
Health Risk |
Likely pathogenic |
Leber congenital amaurosis 5, Leber congenital amaurosis 5 |
| RS2533438863 |
LCA5
|
Health Risk |
Pathogenic |
— |
| RS2533439608 |
LCA5
|
Health Risk |
Likely pathogenic |
Leber congenital amaurosis 5, Leber congenital amaurosis 5 |
| RS2533439675 |
LCA5
|
Health Risk |
Likely pathogenic |
Leber congenital amaurosis 5, Leber congenital amaurosis 5 |
| RS2533439828 |
LCA5
|
Health Risk |
Pathogenic |
Leber congenital amaurosis 5, Leber congenital amaurosis 5 |
| RS2533440056 |
LCA5
|
Health Risk |
Pathogenic |
— |
| RS2533440335 |
LCA5
|
Health Risk |
Pathogenic |
— |
| RS2533440718 |
LCA5
|
Health Risk |
Pathogenic |
— |
| RS2533441301 |
LAMA2
|
Health Risk |
Likely pathogenic |
Merosin deficient congenital muscular dystrophy, Merosin deficient congenital muscular dystrophy |
| RS2533441401 |
LAMA2
|
Health Risk |
Pathogenic/Likely pathogenic |
LAMA2-related muscular dystrophy, Merosin deficient congenital muscular dystrophy |
| RS2533441661 |
LAMA2
|
Health Risk |
Likely pathogenic |
Merosin deficient congenital muscular dystrophy, Muscular dystrophy |
| RS2533441711 |
LAMA2
|
Health Risk |
Likely pathogenic |
Merosin deficient congenital muscular dystrophy, Muscular dystrophy |
| RS2533441727 |
LAMA2
|
Health Risk |
Pathogenic |
LAMA2-related muscular dystrophy, LAMA2-related muscular dystrophy |
| RS2533441844 |
PKHD1
|
Health Risk |
Pathogenic |
Polycystic kidney disease 4, Polycystic kidney disease 4 |
| RS2533442093 |
PKHD1
|
Health Risk |
Pathogenic/Likely pathogenic |
Polycystic kidney disease 4, Autosomal recessive polycystic kidney disease |
| RS2533442206 |
PKHD1
|
Health Risk |
Likely pathogenic |
Polycystic kidney disease 4, Polycystic kidney disease 4 |
| RS2533442330 |
APC
|
Health Risk |
Pathogenic |
Familial adenomatous polyposis 1, Familial adenomatous polyposis 1 |
| RS2533442392 |
PKHD1
|
Health Risk |
Pathogenic |
Autosomal recessive polycystic kidney disease, Autosomal recessive polycystic kidney disease |
| RS2533442999 |
APC
|
Health Risk |
Pathogenic |
Familial adenomatous polyposis 1, Familial adenomatous polyposis 1 |
| RS2533443583 |
LAMA2
|
Health Risk |
Likely pathogenic |
Merosin deficient congenital muscular dystrophy, Muscular dystrophy |
| RS2533443743 |
PKHD1
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive polycystic kidney disease, Polycystic kidney disease 4 |
| RS2533443750 |
LAMA2
|
Health Risk |
Pathogenic |
LAMA2-related muscular dystrophy, LAMA2-related muscular dystrophy |
| RS2533443773 |
LAMA2
|
Health Risk |
Likely pathogenic |
Merosin deficient congenital muscular dystrophy, Muscular dystrophy |
| RS2533443782 |
LAMA2
|
Health Risk |
Pathogenic |
LAMA2-related muscular dystrophy, LAMA2-related muscular dystrophy |
| RS2533443816 |
LAMA2
|
Health Risk |
Likely pathogenic |
Merosin deficient congenital muscular dystrophy, Muscular dystrophy |
| RS2533444880 |
PKHD1
|
Health Risk |
Pathogenic/Likely pathogenic |
Polycystic kidney disease 4, Autosomal recessive polycystic kidney disease |
| RS2533445617 |
APC
|
Health Risk |
Pathogenic/Likely pathogenic |
Familial adenomatous polyposis 1, Familial adenomatous polyposis 1 |
| RS2533445751 |
APC
|
Health Risk |
Pathogenic |
Familial adenomatous polyposis 1, Familial adenomatous polyposis 1 |
| RS2533446257 |
APC
|
Health Risk |
Pathogenic |
Familial adenomatous polyposis 1, Familial adenomatous polyposis 1 |
| RS2533446785 |
PKHD1
|
Health Risk |
Pathogenic |
Autosomal recessive polycystic kidney disease, Autosomal recessive polycystic kidney disease |
| RS2533447467 |
APC
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 1 |
| RS2533447679 |
PKHD1
|
Health Risk |
Likely pathogenic |
Polycystic kidney disease 4, Polycystic kidney disease 4 |
| RS2533447712 |
APC
|
Health Risk |
Pathogenic |
Familial adenomatous polyposis 1, Familial adenomatous polyposis 1 |
| RS2533448516 |
APC
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 1 |
| RS2533450058 |
APC
|
Health Risk |
Pathogenic |
Familial adenomatous polyposis 1, Familial adenomatous polyposis 1 |
| RS2533450166 |
APC
|
Health Risk |
Pathogenic |
Familial adenomatous polyposis 1, Familial adenomatous polyposis 1 |
| RS2533450214 |
SLC17A5
|
Health Risk |
Pathogenic |
Salla disease, Salla disease |
| RS2533450264 |
DNAH8
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS2533450349 |
SLC17A5
|
Health Risk |
Pathogenic |
Salla disease, Sialic acid storage disease |
| RS2533450703 |
APC
|
Health Risk |
Pathogenic |
Familial adenomatous polyposis 1, Colorectal cancer |
| RS2533450732 |
SLC17A5
|
Health Risk |
Likely pathogenic |
Salla disease, Sialic acid storage disease |
| RS2533450792 |
PKHD1
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive polycystic kidney disease, Polycystic kidney disease 4 |
| RS2533450798 |
SLC17A5
|
Health Risk |
Likely pathogenic |
Salla disease, Salla disease |
| RS2533451045 |
LCA5
|
Health Risk |
Pathogenic |
— |